Page last updated: 2024-08-23

paclitaxel and Hepatitis

paclitaxel has been researched along with Hepatitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Arisawa, T; Hayashi, R; Hayashi, T; Horita, T; Kumagai, M; Nakamura, M; Ota, M; Otsuka, T; Sakurai, N; Takano, H; Yamada, S	1

Other Studies

1 other study(ies) available for paclitaxel and Hepatitis

Article	Year
Durvalumab-induced Immune-related Hepatitis in a Patient with Non-small Cell Lung Cancer. Internal medicine (Tokyo, Japan), 2020, Nov-01, Volume: 59, Issue:21 Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Female; Hepatitis; Humans; Japan; Lung Neoplasms; Male; Paclitaxel	2020

Article

Year

Durvalumab-induced Immune-related Hepatitis in a Patient with Non-small Cell Lung Cancer.

Internal medicine (Tokyo, Japan), 2020, Nov-01, Volume: 59, Issue:21

Topics: Aged; Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Female; Hepatitis; Humans; Japan; Lung Neoplasms; Male; Paclitaxel

2020